Atossa Therapeutics (ATOS) Return on Equity (ROE) (2012 - 2026)
Atossa Therapeutics (ATOS) Return on Equity (ROE) from Sep 30, 2012 to Mar 31, 2026. The TTM Atossa Therapeutics (ATOS) Return on Equity (ROE) is -31.45%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Atossa Therapeutics (ATOS)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -88.36% | +147.69% |
| 2024 | -35.67% | +7.91% |
| 2023 | -33.06% | +44.64% |
| 2022 | -22.86% | +53.19% |
| 2021 | -14.92% | -77.26% |
| 2020 | -65.62% | -49.91% |
| 2019 | -131.00% | +1.24% |
| 2018 | -129.40% | +10.59% |
| 2017 | -117.00% | -43.06% |
| 2016 | -205.48% | N/A |
| 2016 | -205.48% | -51.24% |
| 2015 | -421.39% | N/A |
| 2015 | -421.39% | +173.07% |
| 2014 | -154.32% | +51.74% |
| 2013 | -101.70% | +3.70% |
| 2012 | -98.07% | -176.48% |
| 2010 | 128.24% | N/A |